Navigation Links
Wonder Drug For Weight Loss Launched In UK

An innovative new drug, which would help people lose weight, will be launched in the UK.This new wonder drug Acomplia is a new weight loss preparation that controls //the desire to over-eat and it has been reported that the British patients will be the first ones worldwide to have access to the medication.

It has been explained that this drug acts by causing weight loss by blocking the brain's craving signals, thereby suppressing the appetite. It is the first drug of its kind as not only does it work well in aiding weight loss, it also controls diabetes and manages cholesterol.

Researchers have explained that the trials of the drug have shown that almost 10% body weight reduction can be achieved within a year, which therein reduces the risk of diabetes and heart disease. Targeting the obese, to help them loose extra pound, many health experts feel that this revolutionary drug could be of benefit for millions of people in UK alone suffering from obesity.

Acomplia, also known, as Rimonabant a new generation of drugs specifically designed to help restrain yearning for food and it is supposed to be taken each day before breakfast. It has been announced that the drug would be available in the form of a pill, in the market from today and would cost £55.20 ($100), a month, as per the official European Union marketing approval last week.

Expectations that millions, could benefit from the probable blockbuster drug, is very high as it is supposed that more than half the adult population world over are obese or overweight. The drug is also expected to be available soon in Denmark, Ireland, Germany, Finland, and Norway later on in the year. Within hours of the launch of the drug there were reports of at least one online Canadian pharmacy that advertised for a four-week supply of the drug at $165.

The French pharmaceutical firm Sanofi-Aventis is manufacturing Acomplia and they are also applying for licenses to market the drug in the U.S. A spokeswoman for Sanofi-Aventis said: 'We believe the right patient for Acomplia is overweight with type two diabetes or low levels of good cholesterol (HDL) or high levels of bad blood fats. It will benefit these people the most because it will also provide improvement above and beyond weight loss alone.'

Professor John Betteridge, a pioneer in the field of medicine who had reviewed the clinical trials, said that the results were fascinating. He said: 'This is a useful new medicine to help overweight people at risk of heart attacks. After a year, people on the trial had lost up to eight kilograms. It is particularly effective at reducing weight around the waist.' He also added, 'For overweight people, it is important to change lifestyle first but for some that doesn't work so this new medicine will help them.'
'"/>




Related medicine news :

1. Lose Weight With New Wonder Slimming FDA approved Prescription Drug
2. Wonder drug - could end in disaster
3. Have You Ever Wondered How We Perceive Different Sounds?
4. Soy Not Such A Wonder For Health?
5. Have You Ever Wondered Why Male And Female Voices Differ?
6. Herceptin Not A ‘Wonder’ Drug, Says The Lanct
7. Wonder drug Dasatinib gives hopes to leukemia patients
8. Femara: The Wonder Drug to Prevent Relapse of Breast Cancer.
9. Braces Work Wonders In Setting Crooked Teeth Right
10. Daughter Turns Saviour: Ailing Mother Provided Wonder Drug Herceptin, To Fight Cancer
11. Save Budhia - The Indian Wonder Kid
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:4/29/2016)... ... April 29, 2016 , ... ... announces the addition Onnit brand Alpha BRAIN and New Mood Daily-Stress Formula for ... and mood optimization products to the store is just one more way Shamangelic ...
(Date:4/29/2016)... ... April 29, 2016 , ... The White House announced ... loans, more information about their loan terms and accounts, and more protections for ... including federal and private loans, has reached $1.3 trillion, with 43 million Americans ...
(Date:4/29/2016)... , ... April 29, 2016 , ... ... that student team BioCellection won the $30,000 Perlman Grand Prize of the 2016 ... Gloeckner Undergraduate Award, the Michelson People’s Choice Award, and the Committee Award for ...
(Date:4/29/2016)... ... , ... Dr. Robert Mondavi, one of the dentists in Torrance , ... fast-growing field as more patients are discovering the many different ways they can change ... currently available to them and which ones might work for their smiles. , ...
(Date:4/29/2016)... ... April 29, 2016 , ... Innovations with Ed Begley ... upcoming episode, airing third quarter 2016 via Discovery Channel. Dates and show times ... Dairy Products, located in Greenwood, Wisconsin applies product research and development and continuous ...
Breaking Medicine News(10 mins):
(Date:4/28/2016)... -- Treato , the single largest ... that it has been named a Cool Vendor by ... Sciences, 2016, Stephen Davies , Michael ... life-science- oriented analytics, algorithms and smart machine technology in ... medication ingestion, and analyze unstructured information.   ...
(Date:4/28/2016)... , April 28, 2016  ValGenesis, Inc., ... Management Solutions (VLMS) today announced that a ... for sufferers of chronic kidney failure has ... manage their corporate validation process. The global ... software solution to manage their validation processes ...
(Date:4/27/2016)... , le 27 Avril 2016 ... d,affaires a progressé de +5% sur le trimestre, ... récurrentes de consommables  Croissance de +16% ... Mauna Kea Technologies (Euronext : MKEA, ... d,endomicroscopie confocale laser, annonce aujourd,hui son chiffre d,affaires ...
Breaking Medicine Technology: